Maarrawi J, Mertens P, Peyron R, Garcia-Larrea L, Sindou M
(Faculty of Medicine) and Hôtel-Dieu de France Hospital (Department of Neurosurgery), St Joseph University, Beirut, Lebanon.
Adv Tech Stand Neurosurg. 2011(37):25-63. doi: 10.1007/978-3-7091-0673-0_2.
Neuropathic pain (NP) may become refractory to conservative medical management, necessitating neurosurgical procedures in carefully selected cases. In this context, the functional neurosurgeon must have suitable knowledge of the disease he or she intends to treat, especially its pathophysiology. This latter factor has been studied thanks to advances in the functional exploration of NP, which will be detailed in this review. The study of the flexion reflex is a useful tool for clinical and pharmacological pain assessment and for exploring the mechanisms of pain at multiple levels. The main use of evoked potentials is to confirm clinical, or detect subclinical, dysfunction in peripheral and central somato-sensory pain pathways. LEP and SEP techniques are especially useful when used in combination, allowing the exploration of both pain and somato-sensory pathways. PET scans and fMRI documented rCBF increases to noxious stimuli. In patients with chronic NP, a decreased resting rCBF is observed in the contralateral thalamus, which may be reversed using analgesic procedures. Abnormal pain evoked by innocuous stimuli (allodynia) has been associated with amplification of the thalamic, insular and SII responses, concomitant to a paradoxical CBF decrease in ACC. Multiple PET studies showed that endogenous opioid secretion is very likely to occur as a reaction to pain. In addition, brain opioid receptors (OR) remain relatively untouched in peripheral NP, while a loss of ORs is most likely to occur in central NP, within the medial nociceptive pathways. PET receptor studies have also proved that antalgic Motor Cortex Stimulation (MCS), indicated in severe refractory NP, induces endogenous opioid secretion in key areas of the endogenous opioid system, which may explain one of the mechanisms of action of this procedure, since the secretion is proportional to the analgesic effect.
神经性疼痛(NP)可能会对保守药物治疗产生耐药性,因此在经过精心挑选的病例中需要进行神经外科手术。在这种情况下,功能神经外科医生必须对其打算治疗的疾病有充分的了解,尤其是其病理生理学。由于NP功能探索方面的进展,对后一个因素进行了研究,本综述将对此进行详细阐述。屈曲反射的研究是临床和药理学疼痛评估以及在多个层面探索疼痛机制的有用工具。诱发电位的主要用途是确认外周和中枢躯体感觉疼痛通路中的临床功能障碍或检测亚临床功能障碍。当联合使用时,体感诱发电位(SEP)和脑干听觉诱发电位(LEP)技术特别有用,可用于探索疼痛和躯体感觉通路。正电子发射断层扫描(PET)和功能磁共振成像(fMRI)记录了有害刺激引起的局部脑血流(rCBF)增加。在慢性NP患者中,对侧丘脑的静息rCBF降低,使用镇痛程序可能会使其逆转。无害刺激引起的异常疼痛(痛觉过敏)与丘脑、岛叶和第二躯体感觉区(SII)反应的增强有关,同时前扣带回皮质(ACC)的CBF出现反常降低。多项PET研究表明,内源性阿片类物质很可能作为对疼痛的反应而分泌。此外,在外周NP中脑阿片受体(OR)相对未受影响,而在内侧伤害性感受通路的中枢NP中最有可能出现OR的丧失。PET受体研究还证明,用于治疗严重难治性NP的止痛性运动皮质刺激(MCS)可在内源性阿片系统的关键区域诱导内源性阿片类物质分泌,这可能解释了该手术的作用机制之一,因为分泌与镇痛效果成正比。